Sign Up to like & get
recommendations!
0
Published in 2020 at "International immunopharmacology"
DOI: 10.1016/j.intimp.2020.106890
Abstract: Therapeutic options for Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative diseases (PTLD) are currently limited, accompanying with some off-target toxicities. We previously demonstrated that early recovery of Vδ2+ T cells inversely correlated to EBV reactivation after allogeneic…
read more here.
Keywords:
lymphoproliferative cells;
vpa;
cells ebv;
valproic acid ... See more keywords